From Contract Award to Facility Adoption

Winning a federal contract, gaining access to a contract vehicle, or being listed on an approved catalog does not automatically generate orders. A frequent source of frustration, particularly within the emerging MedTech sector, is the expectation that a successful DoD or VA clinical trial, research pilot, or study will naturally transition into facility-level procurement.

In reality, research and clinical evaluation pathways are completely decoupled from operational purchasing budgets. Contract availability and successful trial data simply remove preliminary hurdles; actual product adoption still requires synchronized clinical, operational, administrative, and logistical execution at the local level.

Identify the Full Stakeholder Matrix

The first step is identifying the full matrix of stakeholders who influence the purchasing cycle. These include clinicians, service-line directors, biomedical engineering, infection prevention, logistics, supply chain management, information technology, pharmacy, prosthetics, contracting officers, and executive leadership.

The clinician or researcher who champions a technology during a trial rarely controls the facility's operational budget or the administrative purchasing process, making cross-departmental alignment essential.

Local Demand Must Be Formally Established

Local demand must then be formally established through facility gatekeepers. Even with national contract access or positive trial data, individual facilities require tailored evidence that a solution meets specific clinical, operational, and financial needs.

Within the Department of Veterans Affairs, this gatekeeping is formally managed by facility-level Clinical Product Review Committees (CPRCs), alongside regional standardization groups and value analysis teams.

The CPRC evaluates all new medical devices and supplies prior to facility acquisition, requiring vendors to submit clinical safety and efficacy data, economic justifications, cybersecurity clearances, staff training plans, equipment compatibility verification, and workflow integration plans.

Avoid Pilot Paralysis

Demonstrations, evaluations, and clinical trials often turn into "pilot paralysis" for MedTech companies if they are not explicitly structured with a commercial transition plan.

A trial generates awareness, but without pre-arranged procurement mechanics—such as an active contract vehicle, catalog placement, an identified funding source, and a clear pathway to convert a successful evaluation into a purchase request—clinical enthusiasm fails to yield actionable purchase orders.

Coordinate Procurement Alongside Clinical Engagement

Procurement coordination must happen concurrently with clinical engagement. The ordering team must verify the correct contract pathway, active vendor registration, item numbers, catalog listings, unit-of-issue pricing, and delivery terms.

Furthermore, funding cycles dictate momentum: clinical interest may build for months awaiting operational budget release, whereas fiscal year-end funds require rapid quote generation, vendor onboarding, and immediate delivery readiness.

Facility Adoption Extends Beyond the First Purchase Order

Facility adoption extends well beyond the initial purchase order. Long-term utilization requires comprehensive post-sale support, including site onboarding, biomedical installation, ongoing clinical in-service training, automated replenishment planning, complaint handling, and continuous technical support.

Delivering robust post-sale execution is what bridges the gap between an initial trial or evaluation and sustained, system-wide federal utilization.